These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 34008865)

  • 1. Genetic Polymorphisms of Cytotoxic T-Lymphocyte Antigen 4 (CTLA-4) and clinical outcomes post-allogeneic hematopoietic stem cell transplantation: A systematic review and meta-analysis.
    Najafi A; Alizadeh-Navaei R; Rahimi S; Valadan R; Tehrani M
    Clin Transplant; 2021 Aug; 35(8):e14364. PubMed ID: 34008865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of cytotoxic T-lymphocyte antigen-4 (CTLA-4) single nucleotide polymorphism in donors with clinical outcome after allogeneic hematopoietic stem cell transplantation: a meta-analysis.
    Wang Z; Zhang Y; Du Y; Song F; Gao S
    Hematology; 2021 Dec; 26(1):144-152. PubMed ID: 33491603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CTLA-4 polymorphisms: influence on transplant-related mortality and survival in children undergoing allogeneic hematopoietic stem cell transplantation.
    Hammrich J; Wittig S; Ernst T; Gruhn B
    J Cancer Res Clin Oncol; 2018 Mar; 144(3):587-592. PubMed ID: 29335768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A CT60G>A polymorphism in the CTLA-4 gene of the recipient may confer susceptibility to acute graft versus host disease after allogeneic hematopoietic stem cell transplantation.
    Karabon L; Markiewicz M; Partyka A; Pawlak-Adamska E; Tomkiewicz A; Dzierzak-Mietla M; Kyrcz-Krzemien S; Frydecka I
    Immunogenetics; 2015 Jun; 67(5-6):295-304. PubMed ID: 25940108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Association Between Single-Nucleotide Polymorphisms of Co-Stimulatory Genes Within Non-HLA Region and the Prognosis of Leukemia Patients With Hematopoietic Stem Cell Transplantation.
    Chen DP; Chang SW; Wang PN; Lin WT; Hsu FP; Wang WT; Tseng CP
    Front Immunol; 2021; 12():730507. PubMed ID: 34671352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CTLA-4 polymorphisms and predisposition to digestive system malignancies: a meta-analysis of 31 published studies.
    Li J; Wang W; Sun Y; Zhu Y
    World J Surg Oncol; 2020 Mar; 18(1):55. PubMed ID: 32178688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CTLA-4 polymorphisms and clinical outcome after allogeneic stem cell transplantation from HLA-identical sibling donors.
    Pérez-García A; De la Cámara R; Román-Gómez J; Jiménez-Velasco A; Encuentra M; Nieto JB; de la Rubia J; Urbano-Ispizúa A; Brunet S; Iriondo A; González M; Serrano D; Espigado I; Solano C; Ribera JM; Pujal JM; Hoyos M; Gallardo D;
    Blood; 2007 Jul; 110(1):461-7. PubMed ID: 17384200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CTLA-4 polymorphisms and haplotype correlate with survival in ALL after allogeneic stem cell transplantation from related HLA-haplotype-mismatched donor.
    Qin XY; Wang Y; Li GX; Qin YZ; Wang FR; Xu LP; Chen H; Han W; Wang JZ; Zhang XH; Chang YJ; Liu KY; Jiang ZF; Huang XJ
    J Transl Med; 2016 Apr; 14():100. PubMed ID: 27118383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Association of CTLA-4 rs231775 and rs3087243 Polymorphisms with Latent Autoimmune Diabetes in Adults: A Meta-Analysis.
    Pang H; Luo S; Huang G; Li X; Xie Z; Zhou Z
    Biochem Genet; 2022 Aug; 60(4):1222-1235. PubMed ID: 34822071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of recipient and donor interleukin 6 polymorphisms 174 and 597 with outcome after allogeneic hematopoietic stem cell transplantation in children.
    Wetzel L; Wittig S; Gruhn B
    J Cancer Res Clin Oncol; 2022 Jan; 148(1):255-265. PubMed ID: 34120222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic T-lymphocyte antigen-4 single nucleotide polymorphisms are not associated with outcomes after unrelated donor transplantation: a center for international blood and marrow transplant research analysis.
    Sengsayadeth S; Wang T; Lee SJ; Haagenson MD; Spellman S; Fernandez Viña MA; Muller CR; Verneris MR; Savani BN; Jagasia M
    Biol Blood Marrow Transplant; 2014 Jun; 20(6):900-3. PubMed ID: 24631737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CTLA-4 polymorphism rs231775: Influence on relapse and survival after allogeneic hematopoietic stem cell transplantation in childhood.
    Hammrich J; Wittig S; Ernst T; Gruhn B
    Eur J Haematol; 2019 Mar; 102(3):251-255. PubMed ID: 30465728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Five Snps in Cytotoxic T-Lymphocyte Antigen 4 and Cancer Susceptibility: Evidence from 67 Studies.
    Fang M; Huang W; Mo D; Zhao W; Huang R
    Cell Physiol Biochem; 2018; 47(1):414-427. PubMed ID: 29794444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of CTLA-4 polymorphisms with increased risks of myasthenia gravis.
    Li F; Yuan W; Wu X
    Ann Hum Genet; 2018 Nov; 82(6):358-369. PubMed ID: 30009380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CTLA-4 polymorphisms are associated with treatment outcomes of patients with multiple myeloma receiving bortezomib-based regimens.
    Qin XY; Lu J; Li GX; Wen L; Liu Y; Xu LP; Chang YJ; Liu KY; Jiang ZF; Huang XJ
    Ann Hematol; 2018 Mar; 97(3):485-495. PubMed ID: 29264740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variation in donor CTLA-4 regulatory region is a strong predictor of outcome after allogeneic hematopoietic cell transplantation for hematologic malignancies.
    Jagasia M; Clark WB; Brown-Gentry KD; Crawford DC; Fan KH; Chen H; Kassim A; Greer JP; Engelhardt BG; Savani BN
    Biol Blood Marrow Transplant; 2012 Jul; 18(7):1069-75. PubMed ID: 22178694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of genetic polymorphisms in CTLA-4 and IL-18 with chronic liver diseases: Evidence from a meta-analysis.
    Zhang S; Yang X; Wang W
    Genomics; 2020 Mar; 112(2):1889-1896. PubMed ID: 31698031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes with CD34-Selected Stem Cell Boost for Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.
    Shahzad M; Siddiqui RS; Anwar I; Chaudhary SG; Ali T; Naseem M; Ahmed TF; Ahmed Z; Khurana S; Ahmed N; Balusu R; Singh AK; Hematti P; Callander NS; Abhyankar SH; McGuirk JP; Mushtaq MU
    Transplant Cell Ther; 2021 Oct; 27(10):877.e1-877.e8. PubMed ID: 34284148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional polymorphism of CTLA-4 and ICOS genes in allogeneic hematopoietic stem cell transplantation.
    Wu J; Tang JL; Wu SJ; Lio HY; Yang YC
    Clin Chim Acta; 2009 May; 403(1-2):229-33. PubMed ID: 19332044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic T-lymphocyte antigen 4 haplotype correlates with relapse and survival after allogeneic hematopoietic SCT.
    Murase M; Nishida T; Onizuka M; Inamoto Y; Sugimoto K; Imahashi N; Murata M; Miyamura K; Kodera Y; Inoko H; Naoe T
    Bone Marrow Transplant; 2011 Nov; 46(11):1444-9. PubMed ID: 21170090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.